News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,348 Results
Type
Article (39036)
Company Profile (279)
Press Release (646033)
Section
Business (203859)
Career Advice (1988)
Deals (35362)
Drug Delivery (85)
Drug Development (80797)
Employer Resources (168)
FDA (16086)
Job Trends (14802)
News (344531)
Policy (32434)
Tag
Academia (2530)
Alliances (49071)
Alzheimer's disease (1226)
Approvals (16018)
Artificial intelligence (128)
Bankruptcy (352)
Best Places to Work (11532)
Biotechnology (200)
Breast cancer (118)
Cancer (1066)
Cardiovascular disease (97)
Career advice (1658)
Cell therapy (230)
Clinical research (64210)
Collaboration (376)
Compensation (195)
COVID-19 (2529)
C-suite (93)
Data (1109)
Diabetes (152)
Diagnostics (6135)
Earnings (84810)
Employer resources (146)
Events (109422)
Executive appointments (298)
FDA (16609)
Funding (339)
Gene therapy (176)
GLP-1 (573)
Government (4322)
Healthcare (18668)
Infectious disease (2613)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16290)
Job creations (3623)
Job search strategy (1416)
Layoffs (412)
Legal (7853)
Lung cancer (169)
Manufacturing (174)
Medical device (13172)
Medtech (13177)
Mergers & acquisitions (19136)
Metabolic disorders (396)
Neuroscience (1496)
NextGen Class of 2024 (6499)
Non-profit (4464)
Northern California (1465)
Obesity (227)
Opinion (179)
Patents (101)
People (56239)
Phase I (19937)
Phase II (28279)
Phase III (21090)
Pipeline (452)
Postmarket research (2553)
Preclinical (8485)
Radiopharmaceuticals (235)
Rare diseases (217)
Real estate (5889)
Regulatory (21514)
Research institute (2308)
Resumes & cover letters (349)
Southern California (1285)
Startups (3561)
United States (13276)
Vaccines (548)
Weight loss (166)
Date
Today (141)
Last 7 days (892)
Last 30 days (3722)
Last 365 days (35606)
2024 (32455)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (191)
Asia (37105)
Australia (6055)
California (3279)
Canada (1273)
China (243)
Colorado (143)
Connecticut (146)
Europe (79471)
Florida (448)
Georgia (115)
Illinois (338)
Indiana (194)
Kansas (96)
Maryland (573)
Massachusetts (2570)
Michigan (153)
Minnesota (269)
New Jersey (943)
New York (939)
North Carolina (696)
Northern California (1465)
Ohio (136)
Pennsylvania (835)
South America (1091)
Southern California (1285)
Texas (450)
Utah (89)
Washington State (355)
685,348 Results for "septerna inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Septerna Prices Upsized Initial Public Offering
October 25, 2024
·
4 min read
Biotech Bay
Septerna to Participate in the Jefferies Global Healthcare Conference
Septerna today announced that management will participate in the Jefferies Global Healthcare Conference in New York on Tuesday, June 4, 2024.
May 28, 2024
·
1 min read
Press Releases
Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering
October 31, 2024
·
2 min read
Biotech Bay
Septerna to Present Preclinical Data from GPCR Drug Discovery Engine at ENDO 2024
Septerna today announced that the company will present the first preclinical data on the company’s parathyroid hormone 1 receptor (PTH1R) and thyroid stimulating hormone receptor (TSHR) programs at the Endocrine Society’s Annual Meeting (ENDO 2024) held June 1-4 in Boston.
May 20, 2024
·
4 min read
Biotech Bay
Septerna Presents Preclinical Data at ENDO 2024 Highlighting Therapeutic Potential of its GPCR Drug Discovery Platform
Septerna today presented preclinical data from the company’s parathyroid hormone 1 receptor (PTH1R) program and its thyroid stimulating hormone receptor (TSHR) program which validate the application of the Native Complex Platform™ for drug discovery in endocrine disorders.
June 3, 2024
·
6 min read
Biotech Bay
Septerna to Participate in Upcoming Investor and Industry Conferences
Septerna today announced that members of the management team, including Jeffrey Finer, M.D., Ph.D., Chief Executive Officer and Co-founder, and Liz Bhatt, MS, MBA, Chief Operating Officer, will participate in the following investor and industry conferences.
February 22, 2024
·
1 min read
Drug Development
Septerna Announces Initiation of Phase 1 Clinical Trial with SEP-786, a Novel Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
September 27, 2024
·
4 min read
Press Releases
Septerna Presents New Preclinical Data at ASBMR 2024 Highlighting Therapeutic Potential of Oral Small Molecule Parathyroid Hormone 1 Receptor (PTH1R) Agonists for Hypoparathyroidism
September 30, 2024
·
3 min read
Deals
Septerna Announces Novel GPCR-targeted Program Acquired by Vertex
Septerna today announced that it has signed a definitive asset purchase agreement with Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) under which Vertex has acquired an undisclosed discovery-stage GPCR program.
September 12, 2023
·
3 min read
Business
Septerna Bolsters Leadership Team as the Company Advances its Multi-Product Pipeline Toward Clinical Studies
Septerna announced the addition of David Martin, Ph.D., as Senior Vice President of Development Sciences, and Samira Shaikhly as Chief People Officer to its leadership team.
August 31, 2023
·
5 min read
1 of 68,535
Next
